Top 10 Rebounding Biotech Stocks: IDIX, MDVN, PCYC, REGN, JAZZ, GENE, ELN, RPRX, ONTY, PGNX (Jan 24, 2012)
"Strong Buy" Rated U.S.-Listed Chinese Stocks (March 13, 2012)
Below are the top 10 rebounding Biotech stocks, ranked based on % change from 52-week lows.
Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) is the 1st best rebounding stock in this segment of the market. It has risen 417% from its 52-week low. It is now trading at 91% of its 52-week high. Medivation, Inc. (NASDAQ:MDVN) is the 2nd best rebounding stock in this segment of the market. It has risen 280% from its 52-week low. It is now trading at 89% of its 52-week high. Pharmacyclics, Inc. (NASDAQ:PCYC) is the 3rd best rebounding stock in this segment of the market. It has risen 258% from its 52-week low. It is now trading at 95% of its 52-week high. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is the 4th best rebounding stock in this segment of the market. It has risen 138% from its 52-week low. It is now trading at 97% of its 52-week high. Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) is the 5th best rebounding stock in this segment of the market. It has risen 127% from its 52-week low. It is now trading at 96% of its 52-week high.
Genetic Technologies Limited (ADR) (NASDAQ:GENE) is the 6th best rebounding stock in this segment of the market. It has risen 123% from its 52-week low. It is now trading at 31% of its 52-week high. Elan Corporation, plc (ADR) (NYSE:ELN) is the 7th best rebounding stock in this segment of the market. It has risen 119% from its 52-week low. It is now trading at 95% of its 52-week high. Repros Therapeutics Inc. (NASDAQ:RPRX) is the 8th best rebounding stock in this segment of the market. It has risen 110% from its 52-week low. It is now trading at 73% of its 52-week high. Oncothyreon Inc. (NASDAQ:ONTY) is the 9th best rebounding stock in this segment of the market. It has risen 108% from its 52-week low. It is now trading at 54% of its 52-week high. Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) is the 10th best rebounding stock in this segment of the market. It has risen 108% from its 52-week low. It is now trading at 97% of its 52-week high.
